Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
162644596 178829 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 178829 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
153585580 178854 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4740491 178854 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585418 178857 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4740519 178857 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
148659040 178974 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(Br)n3c2=O)cc1 nan
CHEMBL4741806 178974 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(Br)n3c2=O)cc1 nan
153585598 179025 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 446 5 1 7 1.9 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4742673 179025 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 446 5 1 7 1.9 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
148397968 179045 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4742901 179045 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
147048009 179067 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(Br)cn3c2=O)cc1 nan
CHEMBL4743199 179067 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 388 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(Br)cn3c2=O)cc1 nan
147451915 179097 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4743612 179097 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
152956498 179120 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
CHEMBL4743938 179120 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
153585490 179151 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ncccn2c1=O nan
CHEMBL4744169 179151 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ncccn2c1=O nan
153585688 179168 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4744340 179168 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162647825 179245 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179245 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
152005060 179272 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4745432 179272 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
150944515 179274 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 425 5 2 7 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(NC(=O)OC(C)(C)C)cccn3c2=O)cc1 nan
CHEMBL4745487 179274 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 425 5 2 7 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(NC(=O)OC(C)(C)C)cccn3c2=O)cc1 nan
147626442 179289 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2cn1 nan
CHEMBL4745668 179289 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2cn1 nan
150995037 179329 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4746108 179329 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
162648023 179385 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 2 9 1.5 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4746822 179385 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 2 9 1.5 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585512 179438 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747431 179438 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162650006 179535 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
CHEMBL4748681 179535 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
153585452 179621 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4749705 179621 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)cc1 nan
151976938 179650 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 179650 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
147634500 179688 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 179688 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
149094095 179692 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4750718 179692 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
152023194 179740 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(Cl)cccn3c2=O)cc1 nan
CHEMBL4751203 179740 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(Cl)cccn3c2=O)cc1 nan
153585601 179747 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 478 6 1 8 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4751259 179747 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 478 6 1 8 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCN(C)CC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585718 179751 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 179751 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585541 179790 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
CHEMBL4751720 179790 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
153585550 179802 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4751886 179802 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
153585655 179884 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
CHEMBL4752993 179884 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
147378727 179935 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4753547 179935 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
162653797 179938 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 179938 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
150050373 180003 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 339 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)nc(C)n3c2=O)cc1 nan
CHEMBL4754384 180003 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 339 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)nc(C)n3c2=O)cc1 nan
149101043 180011 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754476 180011 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585478 180013 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754503 180013 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585445 180165 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4756137 180165 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
153585588 180194 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756392 180194 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585712 180199 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756431 180199 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
94095050 180219 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4756787 180219 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585575 180237 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756937 180237 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
162656575 180291 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4757480 180291 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
153585415 180296 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180296 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
162656504 180304 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4757619 180304 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585404 180316 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4757742 180316 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
149421402 180364 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758375 180364 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657688 180463 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
CHEMBL4759611 180463 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
153585534 180492 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 180492 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
162657416 180528 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4760528 180528 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585663 180563 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
CHEMBL4760812 180563 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
153585574 180629 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 180629 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
162660420 180683 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4762121 180683 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
147987797 180692 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 180692 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
153585643 180749 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4762957 180749 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
147323186 180792 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
CHEMBL4763362 180792 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
153585610 180853 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 180853 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
162661581 180872 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 180872 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
153585681 180891 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764666 180891 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
152494840 180905 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764839 180905 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181177 1 None 3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181177 1 None 3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
162665057 181474 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 181474 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
149618414 181669 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
CHEMBL4783739 181669 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
153585453 181676 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 431 6 1 7 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)F)nccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783815 181676 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 431 6 1 7 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)F)nccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585542 181714 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4784153 181714 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
151570395 181795 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n2c1 nan
CHEMBL4785283 181795 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n2c1 nan
153585417 181835 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
CHEMBL4785963 181835 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
162667558 181870 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4786371 181870 0 None 10 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
153585609 181880 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4786573 181880 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151394869 181944 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4787308 181944 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
151043804 182083 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182083 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162670176 182159 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4790080 182159 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
150234341 182198 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4790498 182198 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
149881970 182262 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
CHEMBL4791551 182262 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
149784975 182286 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccncn3c2=O)cc1 nan
CHEMBL4791843 182286 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccncn3c2=O)cc1 nan
162670473 182318 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4792356 182318 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
153585679 182331 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 182331 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162671011 182352 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 182352 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
153585435 182402 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 359 4 1 6 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4793463 182402 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 359 4 1 6 2.0 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
153585524 182538 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
CHEMBL4795078 182538 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
153585386 182641 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 182641 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585438 182768 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
CHEMBL4797724 182768 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
153585532 182800 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 182800 0 None -3 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
162675990 182826 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 375 5 1 6 2.0 O=C(Cn1nc2cccnn2c1=O)N[C@H](c1ccc(Cl)c(F)c1)C1CC1 nan
CHEMBL4798509 182826 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 375 5 1 6 2.0 O=C(Cn1nc2cccnn2c1=O)N[C@H](c1ccc(Cl)c(F)c1)C1CC1 nan
153585488 182875 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4799144 182875 0 None - 1 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585707 182986 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4800487 182986 0 None 1 2 Human 9.0 pEC50 = 9 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
153585650 178814 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4740004 178814 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162644596 178829 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 178829 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648528 179224 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
CHEMBL4744984 179224 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
146867363 179286 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 7 1 8 2.0 C[C@H](NC(=O)Cn1nc2cc(OC3CN(C)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4745642 179286 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 7 1 8 2.0 C[C@H](NC(=O)Cn1nc2cc(OC3CN(C)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162649809 179455 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 179455 0 None 1 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585543 179646 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1 nan
CHEMBL4750043 179646 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1 nan
153585514 179782 0 None -10 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
CHEMBL4751629 179782 0 None -10 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
153585659 180040 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 6 1 7 1.5 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4754933 180040 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 6 1 7 1.5 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
153585592 180151 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 2 8 1.7 C[C@H](NC(=O)Cn1nc2cccc(N3CCNCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4755986 180151 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 2 8 1.7 C[C@H](NC(=O)Cn1nc2cccc(N3CCNCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
133916051 180657 1 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 356 5 1 5 2.4 O=C(Cn1nc2ccccn2c1=O)NC(c1ccc(Cl)cc1)C1CC1 nan
CHEMBL4761733 180657 1 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 356 5 1 5 2.4 O=C(Cn1nc2ccccn2c1=O)NC(c1ccc(Cl)cc1)C1CC1 nan
153065968 180686 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 354 6 1 6 2.2 CC(C)Oc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4762154 180686 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 354 6 1 6 2.2 CC(C)Oc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
153585680 180694 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(F)cc1 nan
CHEMBL4762210 180694 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 314 4 1 5 1.5 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(F)cc1 nan
151392727 181131 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 1 8 2.7 C[C@H](NC(=O)Cn1nc2ccc(N3CCCCC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4777046 181131 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 464 6 1 8 2.7 C[C@H](NC(=O)Cn1nc2ccc(N3CCCCC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181177 1 None 3 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181177 1 None 3 2 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
153585533 181459 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 372 5 1 5 3.0 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(-c2ccccc2)cc1 nan
CHEMBL4781160 181459 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 372 5 1 5 3.0 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(-c2ccccc2)cc1 nan
153585698 181829 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4785855 181829 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)cc1 nan
149374815 181909 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnccn3c2=O)cc1 nan
CHEMBL4786952 181909 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnccn3c2=O)cc1 nan
153585657 181978 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 4 1 5 2.1 O=C(Cn1nc2ccc(F)cn2c1=O)NC1(c2ccc(Cl)cc2)CC1 nan
CHEMBL4787820 181978 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 4 1 5 2.1 O=C(Cn1nc2ccc(F)cn2c1=O)NC1(c2ccc(Cl)cc2)CC1 nan
121349628 181433 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
121349628 181433 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
CHEMBL4780801 181433 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4780801 181433 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
121349739 181578 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4782619 181578 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
121349631 181890 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4786722 181890 0 None - 1 Human 8.0 pEC50 = 8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
122195502 123585 0 None - 1 Human 5.0 pEC50 = 5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 402 8 2 3 3.9 COc1cccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633717 123585 0 None - 1 Human 5.0 pEC50 = 5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 402 8 2 3 3.9 COc1cccc(C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349564 181172 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349564 181172 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4777630 181172 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4777630 181172 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349633 182125 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4789631 182125 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
164628435 185698 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4874254 185698 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
26532940 123588 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633721 123588 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)cc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
164621186 185502 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871591 185502 0 None - 1 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349572 181254 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4778561 181254 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349566 182060 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4788831 182060 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
121349806 182782 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4797857 182782 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
2114212 20715 14 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 5 1 5 1.2 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL1310918 20715 14 None - 1 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 5 1 5 1.2 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1 10.1021/acs.jmedchem.1c00820
121349764 182296 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 360 4 1 5 2.5 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Cl nan
CHEMBL4792090 182296 0 None - 1 Human 7.9 pEC50 = 7.9 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 360 4 1 5 2.5 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Cl nan
36428174 181350 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4779855 181350 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349734 181504 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
CHEMBL4781729 181504 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
121349683 182131 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4789720 182131 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
121349710 182356 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4792828 182356 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349767 182738 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797410 182738 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
2303171 123587 1 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633719 123587 1 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@H](NC(=O)CNC(=O)c1ccccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349643 182854 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 4 1 5 2.6 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Br nan
CHEMBL4798899 182854 0 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 4 1 5 2.6 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1Br nan
164611430 184631 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
CHEMBL4857947 184631 0 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
121349781 181256 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4778563 181256 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349675 181373 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4780038 181373 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349763 181876 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@@H](C)n1nnc2ccccc2c1=O nan
CHEMBL4786501 181876 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@@H](C)n1nnc2ccccc2c1=O nan
121349809 182569 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4795372 182569 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349689 182627 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4796061 182627 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
2548547 2109 39 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
8766 2109 39 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
CHEMBL3633720 2109 39 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 10.1021/acsmedchemlett.5b00247
1555702 123586 2 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 282 5 2 2 2.3 C[C@H](NC(=O)CNC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633718 123586 2 None - 1 Human 6.8 pEC50 = 6.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 282 5 2 2 2.3 C[C@H](NC(=O)CNC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349597 181219 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
CHEMBL4778124 181219 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
121349786 181661 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
CHEMBL4783626 181661 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
28918448 123607 2 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633895 123607 2 None - 1 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349574 182227 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349574 182227 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4790968 182227 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4790968 182227 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
121349782 182452 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4794046 182452 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
121349740 181499 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4781651 181499 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349745 181620 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
121349745 181620 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
CHEMBL4783071 181620 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4783071 181620 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
121349593 182281 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4791792 182281 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
40719079 123599 1 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633885 123599 1 None - 1 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349656 182897 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4799483 182897 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
121349786 181661 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4783626 181661 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349593 182281 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
CHEMBL4791792 182281 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
2695546 185524 12 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871792 185524 12 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
2548543 123608 2 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633896 123608 2 None - 1 Human 5.7 pEC50 = 5.7 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 316 5 2 2 2.9 C[C@@H](NC(=O)CNC(=O)c1cccc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
11685 3667 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
11685 3667 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349608 3667 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
121349608 3667 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
CHEMBL4779773 3667 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
CHEMBL4779773 3667 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
2714485 182350 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 326 4 1 5 1.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1 nan
CHEMBL4792727 182350 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 326 4 1 5 1.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(F)cc1 nan
121349719 182667 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349719 182667 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4796493 182667 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4796493 182667 0 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
8036946 182847 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798779 182847 2 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349614 181073 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
CHEMBL4776329 181073 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
27783537 181091 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 nan
CHEMBL4776509 181091 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 nan
121349728 181224 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349728 181224 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
CHEMBL4778172 181224 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4778172 181224 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
41757362 181621 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4783081 181621 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349658 182111 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4789475 182111 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
27785340 182879 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4799237 182879 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
27754276 185339 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869182 185339 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
7534868 123592 2 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 296 5 2 2 2.6 Cc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633878 123592 2 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 296 5 2 2 2.6 Cc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
122195644 123602 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 334 5 2 2 3.1 C[C@H](NC(=O)CNC(=O)c1cc(F)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633888 123602 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 334 5 2 2 3.1 C[C@H](NC(=O)CNC(=O)c1cc(F)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349701 181352 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
CHEMBL4779884 181352 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
121349805 182528 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
CHEMBL4794908 182528 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
121349755 181211 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4778062 181211 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349734 181504 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4781729 181504 0 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
27785340 182879 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4799237 182879 1 None - 1 Human 7.6 pEC50 = 7.6 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
122195501 123584 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 3 4 1.7 COc1cccc(C(=O)N[C@@H](CO)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633716 123584 0 None - 1 Human 6.6 pEC50 = 6.6 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 3 4 1.7 COc1cccc(C(=O)N[C@@H](CO)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
8036887 184147 1 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4850747 184147 1 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349639 181825 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349639 181825 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4785741 181825 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4785741 181825 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
3341369 47366 7 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 328 4 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1546963 47366 7 None - 1 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 328 4 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349694 181623 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
121349694 181623 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
CHEMBL4783106 181623 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
CHEMBL4783106 181623 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
121349596 182849 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798863 182849 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
164609046 183893 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847108 183893 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349780 185777 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4875522 185777 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349738 181505 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4781754 181505 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349572 181254 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4778561 181254 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
2109722 123604 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 2 4 2.3 COc1cc(OC)cc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633890 123604 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 342 7 2 4 2.3 COc1cc(OC)cc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349658 182111 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
CHEMBL4789475 182111 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
121349548 182837 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798667 182837 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
8036946 182847 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4798779 182847 2 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
26810968 185691 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
CHEMBL4874147 185691 0 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
28918445 123595 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633881 123595 1 None - 1 Human 7.5 pEC50 = 7.5 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 312 6 2 3 2.3 COc1cccc(C(=O)NCC(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349633 182125 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4789631 182125 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
121349767 182738 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
CHEMBL4797410 182738 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
121349559 181244 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
CHEMBL4778354 181244 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
121349615 182533 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4795005 182533 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349746 182792 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797979 182792 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349645 181126 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4776988 181126 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349720 181651 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
CHEMBL4783544 181651 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
122195642 123600 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633886 123600 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349688 182306 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4792174 182306 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349659 181673 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4783774 181673 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349600 181993 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4788013 181993 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
3376937 123605 45 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 365 4 3 4 3.3 COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633893 123605 45 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 365 4 3 4 3.3 COc1cc(OC)cc(C(=O)NNC(=O)Nc2cccc3ccccc23)c1 10.1021/acsmedchemlett.5b00247
122195500 123583 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633715 123583 0 None - 1 Human 6.4 pEC50 = 6.4 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
121349746 182792 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4797979 182792 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
2496250 28724 7 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1380104 28724 7 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
122195640 123597 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 366 6 2 3 3.2 C[C@H](NC(=O)CNC(=O)c1cccc(OC(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633883 123597 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 366 6 2 3 3.2 C[C@H](NC(=O)CNC(=O)c1cccc(OC(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
122195643 123601 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633887 123601 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Cl)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349558 181380 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4780121 181380 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
121349685 181541 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4782204 181541 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
121349623 181508 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
CHEMBL4781805 181508 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
121349588 181644 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783365 181644 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349773 181836 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
CHEMBL4785980 181836 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
121349793 181231 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@H](C)n1nnc2ccccc2c1=O nan
CHEMBL4778263 181231 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 366 5 1 6 2.5 COc1cc(C)ccc1[C@H](C)NC(=O)[C@H](C)n1nnc2ccccc2c1=O nan
122195639 123596 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.3 C[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633882 123596 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.3 C[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
122195641 123598 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633884 123598 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 350 5 2 2 3.6 C[C@H](NC(=O)CNC(=O)c1cccc(Cl)c1Cl)c1ccccc1 10.1021/acsmedchemlett.5b00247
2714528 181886 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
CHEMBL4786641 181886 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
2714527 184813 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4861019 184813 2 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349679 185676 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4873905 185676 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
28821961 123594 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 300 5 2 2 2.4 C[C@H](NC(=O)CNC(=O)c1cccc(F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633880 123594 0 None - 1 Human 7.3 pEC50 = 7.3 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 300 5 2 2 2.4 C[C@H](NC(=O)CNC(=O)c1cccc(F)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349685 181541 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4782204 181541 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
122195638 123593 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 307 5 2 3 2.2 C[C@H](NC(=O)CNC(=O)c1cccc(C#N)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633879 123593 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 307 5 2 3 2.2 C[C@H](NC(=O)CNC(=O)c1cccc(C#N)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
121349795 182857 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4798933 182857 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
27838947 184839 2 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4861445 184839 2 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
2998350 37855 6 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 334 3 1 5 2.0 O=C(Cn1nnc2ccccc2c1=O)NC1CCCc2ccccc21 10.1021/acs.jmedchem.1c00820
CHEMBL1460960 37855 6 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 334 3 1 5 2.0 O=C(Cn1nnc2ccccc2c1=O)NC1CCCc2ccccc21 10.1021/acs.jmedchem.1c00820
122195499 123582 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
CHEMBL3633714 123582 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 326 6 2 3 2.7 COc1cccc(C(=O)N[C@@H](C)C(=O)N[C@@H](C)c2ccccc2)c1 10.1021/acsmedchemlett.5b00247
41757362 181621 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4783081 181621 1 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349753 182302 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
CHEMBL4792136 182302 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
2856847 123606 10 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 299 5 1 3 3.4 CC(NC(=O)CSC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633894 123606 10 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 299 5 1 3 3.4 CC(NC(=O)CSC(=O)c1ccccc1)c1ccccc1 10.1021/acsmedchemlett.5b00247
164619649 185174 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
CHEMBL4866435 185174 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
121349671 181161 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4777495 181161 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349778 181764 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4784744 181764 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349756 181975 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4787761 181975 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
121349555 182045 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4788631 182045 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349787 182080 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4789079 182080 0 None - 1 Human 8.2 pEC50 = 8.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349554 182947 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
CHEMBL4800089 182947 0 None - 1 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
164617704 183939 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 7 1.4 COc1ccc([C@H](C)NS(=O)(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847795 183939 0 None - 1 Human 6.2 pEC50 = 6.2 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 374 6 1 7 1.4 COc1ccc([C@H](C)NS(=O)(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
164617980 184436 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
CHEMBL4855076 184436 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
122195645 123603 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 394 5 2 2 3.7 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Br)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
CHEMBL3633889 123603 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assayAgonist activity at human GPR139 receptor expressed in HEK293 cells assessed as calcium mobilization by FLIPR assay
ChEMBL 394 5 2 2 3.7 C[C@H](NC(=O)CNC(=O)c1cc(Cl)cc(Br)c1)c1ccccc1 10.1021/acsmedchemlett.5b00247
78596259 184783 1 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4860510 184783 1 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349587 181820 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4785669 181820 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
164620660 185353 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 384 6 1 5 2.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(-c2ccccc2)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869485 185353 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 384 6 1 5 2.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(-c2ccccc2)cc1 10.1021/acs.jmedchem.1c00820
27783537 181091 1 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4776509 181091 1 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
121349569 181323 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4779481 181323 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349561 182138 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4789791 182138 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349769 182335 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4792561 182335 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349596 182849 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798863 182849 0 None - 1 Human 8.1 pEC50 = 8.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
164620725 185493 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871506 185493 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
36428174 181350 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4779855 181350 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349753 182302 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4792136 182302 0 None - 1 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assayAgonist activity at human GPR139 expressed in CHO-TRex cells assessed as stimulation of calcium signalling incubated for 15 mins by FLIPR assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
11685 3667 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
121349608 3667 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
CHEMBL4779773 3667 17 None - 1 Human 7.7 pEC50 = 7.7 Functional
Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139Agonist-induced <i>in vitro</i> calcium mobilization assay, using CHO-T-REx cells stably expressing hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
2144 2314 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
3313 2314 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
6140 2314 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
6925665 2314 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
CHEMBL301523 2314 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
DB00120 2314 0 None - 1 Human 3.5 pEC50 = 3.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 24826842
2780 2331 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
6305 2331 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
6923516 2331 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
717 2331 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
CHEMBL54976 2331 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
DB00150 2331 101 None 13 2 Human 3.7 pEC50 = 3.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 24826842
7799 994 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 365 4 3 4 3.3 COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1ccc2c(c1)cccc2 24900311
86277840 994 0 None - 1 Human 7.4 pEC50 = 7.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 365 4 3 4 3.3 COc1cc(OC)cc(c1)C(=O)NNC(=O)Nc1ccc2c(c1)cccc2 24900311
2144 2314 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
3313 2314 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
6140 2314 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
6925665 2314 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
CHEMBL301523 2314 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
DB00120 2314 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 None
2780 2331 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
6305 2331 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
6923516 2331 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
717 2331 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
CHEMBL54976 2331 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
DB00150 2331 101 None 13 2 Human 8.3 pIC50 = 8.3 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Drug Central 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N None
12363 2700 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of Ca<sup>2+</sup> mobilizationInhibition of Ca<sup>2+</sup> mobilization
Guide to Pharmacology 340 1 1 3 4.8 Oc1cc2c(cc1)c(=O)c(c1ccc(Cl)cc1)c(o2)C(F)(F)F 36736525
5348723 2700 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Inhibition of Ca<sup>2+</sup> mobilizationInhibition of Ca<sup>2+</sup> mobilization
Guide to Pharmacology 340 1 1 3 4.8 Oc1cc2c(cc1)c(=O)c(c1ccc(Cl)cc1)c(o2)C(F)(F)F 36736525
2144 2314 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
3313 2314 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6140 2314 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6925665 2314 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
CHEMBL301523 2314 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
DB00120 2314 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
2780 2331 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6305 2331 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6923516 2331 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
717 2331 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
CHEMBL54976 2331 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
DB00150 2331 101 None 13 2 Human 4.6 pIC50 = 4.6 Functional
Measured using a GTP&gamma;S assay in transfected COS7 cells.Measured using a GTP&gamma;S assay in transfected COS7 cells.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
789353 2312 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 329 4 1 2 4.8 Cc1ccccc1NS(=O)(=O)c1ccc(cc1)C1CCCCC1 19525486
8774 2312 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 329 4 1 2 4.8 Cc1ccccc1NS(=O)(=O)c1ccc(cc1)C1CCCCC1 19525486
5017692 2699 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 289 3 0 2 3.4 COc1ccc(cc1)C1N(c2ccccc2)C(=O)C1(F)F 26027661
8775 2699 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 289 3 0 2 3.4 COc1ccc(cc1)C1N(c2ccccc2)C(=O)C1(F)F 26027661




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
153585580 178854 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4740491 178854 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 411 6 1 8 1.7 COc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
148397968 179045 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4742901 179045 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
153585666 179047 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 1 6 2.2 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4742949 179047 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 1 6 2.2 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
147451915 179097 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4743612 179097 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585625 179103 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)ccn3c2=O)cc1 nan
CHEMBL4743662 179103 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(C)ccn3c2=O)cc1 nan
153585420 179220 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4744927 179220 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
153585722 179357 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4746401 179357 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
162649907 179493 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 2 7 1.6 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4748076 179493 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 378 5 2 7 1.6 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
152844759 179509 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4748306 179509 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585686 179663 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4750288 179663 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
147641221 179706 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
CHEMBL4750914 179706 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
153585718 179751 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 179751 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585581 179771 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751501 179771 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585708 179865 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4752808 179865 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 348 4 1 5 2.2 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)cc1 nan
153585648 179925 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 366 4 1 5 2.3 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4753388 179925 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 366 4 1 5 2.3 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162653764 179941 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2cc(C3CC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4753640 179941 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2cc(C3CC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585540 180016 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754565 180016 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585467 180017 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4754576 180017 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 1 7 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
152015494 180031 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2c(C3CC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4754735 180031 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2c(C3CC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
150352344 180179 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756243 180179 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(Cl)c(F)c1 nan
162655689 180191 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4756356 180191 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
153585712 180199 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756431 180199 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 419 6 2 7 2.0 C[C@H](NC(=O)Cn1nc2cc(NC3COC3)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585415 180296 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180296 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
153585630 180403 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 346 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1F nan
CHEMBL4758841 180403 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 346 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1F nan
153585534 180492 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 180492 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
153585651 180610 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 382 4 1 5 2.8 C[C@H](NC(=O)Cn1nc2cc(Cl)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761154 180610 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 382 4 1 5 2.8 C[C@H](NC(=O)Cn1nc2cc(Cl)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585591 180684 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
CHEMBL4762126 180684 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
162659465 180728 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4762651 180728 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585610 180853 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 180853 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
153585689 180914 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2c1 nan
CHEMBL4764967 180914 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2c1 nan
162661302 180925 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4765018 180925 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585427 181389 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(C)cn3c2=O)cc1 nan
CHEMBL4780358 181389 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 324 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(C)cn3c2=O)cc1 nan
153585638 181608 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4782901 181608 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 379 5 1 7 1.6 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
153585409 181879 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
CHEMBL4786542 181879 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 394 5 1 6 2.6 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2c1 nan
147410414 182089 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4789252 182089 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
153585385 182225 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
CHEMBL4790949 182225 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
162671538 182237 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 417 4 1 6 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)(F)F)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4791193 182237 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 417 4 1 6 2.6 C[C@H](NC(=O)Cn1nc2c(C(F)(F)F)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162671011 182352 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 182352 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
148156995 182363 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4792896 182363 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151533016 182378 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 339 5 2 6 1.7 CNc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
CHEMBL4793093 182378 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 339 5 2 6 1.7 CNc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
153585429 182820 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
CHEMBL4798385 182820 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
153585699 182909 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.5 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4799647 182909 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.5 Cc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
153585528 182972 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
CHEMBL4800338 182972 0 None - 0 Human 9.0 pEC50 = 9 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
162644596 178829 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 178829 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
153585418 178857 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4740519 178857 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 434 5 1 8 1.4 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585684 178943 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 4 1 6 2.2 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
CHEMBL4741467 178943 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 4 1 6 2.2 Cc1cc(C)n2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2n1 nan
152956498 179120 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
CHEMBL4743938 179120 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 324 4 1 5 2.2 Cc1ccc([C@H](C)NC(=O)C(C)n2nc3ccccn3c2=O)cc1 nan
153585688 179168 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4744340 179168 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162648790 179197 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4744737 179197 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
153585420 179220 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4744927 179220 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.7 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
162647825 179245 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179245 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
152005060 179272 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4745432 179272 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 8 1.3 C[C@H](NC(=O)Cn1nc2c(N3CCN(C)CC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
150995037 179329 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4746108 179329 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cnccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585512 179438 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747431 179438 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 367 4 1 6 1.7 C[C@H](NC(=O)Cn1nc2ncc(F)cn2c1=O)c1ccc(Cl)c(F)c1 nan
162650006 179535 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
CHEMBL4748681 179535 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2cccnn2c1=O nan
151976938 179650 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 179650 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
153585686 179663 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
CHEMBL4750288 179663 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n12 nan
147634500 179688 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 179688 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
147641221 179706 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
CHEMBL4750914 179706 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1 nan
153585718 179751 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751304 179751 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2cc(C#N)ccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585721 179760 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2ncc(Cl)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751414 179760 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2ncc(Cl)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585581 179771 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4751501 179771 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 373 4 1 6 2.0 C[C@H](NC(=O)Cn1nc2ccc(C#N)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585514 179782 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
CHEMBL4751629 179782 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 311 4 1 6 1.1 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1 nan
153585541 179790 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
CHEMBL4751720 179790 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 341 5 1 7 1.1 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc2n1 nan
162653366 179868 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4752829 179868 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
153585655 179884 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
CHEMBL4752993 179884 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 493 7 1 8 2.9 COC1CCN(c2ccn3c(=O)n(CC(=O)N[C@@H](C)c4ccc(OC(F)(F)F)cc4)nc3c2)CC1 nan
153585421 179929 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 7 2.4 CC1COCCN1c1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4753419 179929 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 447 5 1 7 2.4 CC1COCCN1c1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
147378727 179935 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
CHEMBL4753547 179935 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 6 1 6 2.1 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)c(F)c1 nan
162653797 179938 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 179938 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
148512747 179965 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1nccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4753915 179965 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 395 5 1 7 2.0 Cc1nccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
149101043 180011 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754476 180011 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585478 180013 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754503 180013 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC[C@H](O)C3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585540 180016 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4754565 180016 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 398 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585445 180165 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4756137 180165 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 382 4 1 5 2.5 C[C@H](NC(=O)Cn1nc2ccc(F)cn2c1=O)c1ccc(C(F)(F)F)cc1 nan
94095050 180219 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4756787 180219 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 380 5 1 6 2.3 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657043 180230 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 379 5 1 7 1.6 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
CHEMBL4756879 180230 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 379 5 1 7 1.6 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
162656575 180291 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4757480 180291 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)c(F)c1 nan
162656504 180304 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4757619 180304 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
152460205 180342 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 451 6 2 8 1.5 C[C@H](NC(=O)Cn1nc2cccc(N3CC(O)C3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758096 180342 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 451 6 2 8 1.5 C[C@H](NC(=O)Cn1nc2cccc(N3CC(O)C3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585448 180358 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
CHEMBL4758322 180358 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 411 6 1 8 1.7 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc2n1 nan
149421402 180364 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4758375 180364 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 452 7 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(OC3COC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162657688 180463 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
CHEMBL4759611 180463 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1cc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)ccc1Cl nan
162657416 180528 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
CHEMBL4760528 180528 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc2c1 nan
150924716 180574 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
CHEMBL4760914 180574 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nc12 nan
153585574 180629 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 180629 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
162660420 180683 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4762121 180683 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 5 1 6 2.0 CC[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585591 180684 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
CHEMBL4762126 180684 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)ccc1Cl nan
147987797 180692 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 180692 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
147323186 180792 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
CHEMBL4763362 180792 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 1 6 1.4 Cc1ccc([C@H](C)NC(=O)Cn2nc3cnc(C)cn3c2=O)cc1 nan
153585610 180853 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
CHEMBL4764290 180853 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1cc(Cl)ccc1[C@H](C)NC(=O)Cn1nc2ccccn2c1=O nan
162661581 180872 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 180872 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
152494840 180905 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4764839 180905 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 479 6 2 8 2.2 C[C@H](NC(=O)Cn1nc2cc(N3CCC(O)CC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162661302 180925 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4765018 180925 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 383 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2cc(Cl)cnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585547 181149 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4777214 181149 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162644369 181238 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
CHEMBL4778327 181238 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
162665057 181474 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 181474 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
150561998 181539 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 475 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4782195 181539 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 475 4 1 6 2.2 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
149618414 181669 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
CHEMBL4783739 181669 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 325 4 2 6 1.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(N)cccn3c2=O)cc1 nan
153585463 181815 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCOCC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4785639 181815 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2cccc(N3CCOCC3)n2c1=O)c1ccc(Cl)c(F)c1 nan
153585417 181835 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
CHEMBL4785963 181835 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1Cl nan
153585609 181880 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4786573 181880 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 465 6 1 8 2.1 C[C@H](NC(=O)Cn1nc2cc(N3CCOCC3)ccn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151394869 181944 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4787308 181944 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585701 181961 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 463 6 1 7 3.3 C[C@H](NC(=O)Cn1nc2cccc(N3CCCCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4787547 181961 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 463 6 1 7 3.3 C[C@H](NC(=O)Cn1nc2cccc(N3CCCCC3)n2c1=O)c1ccc(OC(F)(F)F)cc1 nan
151043804 182083 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182083 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162670176 182159 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4790080 182159 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 377 5 1 6 2.2 CC(C)[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585385 182225 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
CHEMBL4790949 182225 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 360 5 1 6 2.0 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n12 nan
153585679 182331 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 182331 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162671011 182352 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
CHEMBL4792732 182352 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)c(=O)n2n1 nan
148156995 182363 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4792896 182363 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 460 8 2 8 2.3 C[C@H](NC(=O)Cn1nc2c(NCC(F)F)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585524 182538 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
CHEMBL4795078 182538 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(F)cccn3c2=O)cc1 nan
153585504 182619 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
CHEMBL4795956 182619 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 410 6 1 7 2.3 COc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)n2c1 nan
153585386 182641 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 182641 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585438 182768 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
CHEMBL4797724 182768 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2c1 nan
153585532 182800 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 182800 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
153585429 182820 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
CHEMBL4798385 182820 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 340 5 1 6 1.7 COc1cccc2nn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)n12 nan
153585528 182972 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
CHEMBL4800338 182972 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 344 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1Cl nan
153585707 182986 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
CHEMBL4800487 182986 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 361 5 1 7 1.4 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)cc3)nc2n1 nan
162644596 178829 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 178829 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648790 179197 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
CHEMBL4744737 179197 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)nc12 nan
162647825 179245 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
CHEMBL4745096 179245 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 399 5 1 7 1.8 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)c(F)c1 nan
162649809 179455 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 179455 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
151976938 179650 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
CHEMBL4750143 179650 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 310 4 1 5 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccccn3c2=O)cc1 nan
147634500 179688 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
CHEMBL4750692 179688 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ncc([C@H](C)NC(=O)Cn2nc3cc(Cl)ccn3c2=O)cc1F nan
149094095 179692 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4750718 179692 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 421 6 1 7 2.5 C[C@H](NC(=O)Cn1nc2ccc(C3CC3)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162653366 179868 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
CHEMBL4752829 179868 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 410 6 2 8 1.7 CNc1ccnn2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nc12 nan
162653797 179938 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
CHEMBL4753587 179938 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccnn3c2=O)cc1F nan
152007746 179974 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
CHEMBL4754043 179974 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
153585713 180379 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1 nan
CHEMBL4758561 180379 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3ccc(F)cn3c2=O)cc1 nan
153585574 180629 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4761321 180629 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 2.1 C[C@H](NC(=O)[C@@H](C)n1nc2ncccn2c1=O)c1ccc(Cl)c(F)c1 nan
147987797 180692 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4762206 180692 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 364 4 1 5 2.4 C[C@H](NC(=O)Cn1nc2ccccn2c1=O)c1ccc(C(F)(F)F)cc1 nan
162661581 180872 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
CHEMBL4764506 180872 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 362 4 1 5 2.7 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ccccn2c1=O nan
153585547 181149 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4777214 181149 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 420 6 2 8 1.4 C[C@H](NC(=O)Cn1nc2c(NC3COC3)ccnn2c1=O)c1ccc(Cl)c(F)c1 nan
162644369 181238 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
CHEMBL4778327 181238 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 343 4 1 6 1.5 Cc1ccc([C@H](C)NC(=O)Cn2nc3c(C)ccnn3c2=O)cc1F nan
162665057 181474 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4781404 181474 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(Cl)c1 nan
151043804 182083 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4789123 182083 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 349 4 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)c(F)c1 nan
153585679 182331 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
CHEMBL4792515 182331 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 329 4 1 6 1.2 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1F nan
162670606 182346 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
CHEMBL4792682 182346 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 363 4 1 6 1.9 Cc1ccc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n2n1 nan
153585386 182641 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4796254 182641 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 415 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2ccc(Cl)nn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
153585532 182800 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
CHEMBL4798029 182800 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 328 4 1 5 1.8 Cc1ccc([C@H](C)NC(=O)Cn2nc3cccc(F)n3c2=O)cc1 nan
147477854 182906 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2c(N3CCOCC3)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4799618 182906 0 None - 0 Human 8.0 pEC50 = 8 Binding
Agonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assayAgonist activity at human GPR139 expressed in CHO-K1 cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by PathHunter assay
ChEMBL 433 5 1 7 2.0 C[C@H](NC(=O)Cn1nc2c(N3CCOCC3)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
162644596 178829 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
CHEMBL4740228 178829 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2cccnn2c1=O nan
162648528 179224 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
CHEMBL4744984 179224 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 337 5 1 6 1.6 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(C2CC2)cc1 nan
146976458 179440 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 507 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4747440 179440 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 507 5 1 7 2.3 C[C@H](NC(=O)Cn1nc2c(I)ccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
162649809 179455 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4747632 179455 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 458 5 1 7 2.1 C[C@H](NC(=O)Cn1nc2c(N3CCC34CN(C)C4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
152844759 179509 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4748306 179509 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 389 5 1 6 2.4 C[C@H](NC(=O)Cn1nc2ncc(C3CC3)cn2c1=O)c1ccc(Cl)c(F)c1 nan
153585550 179802 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
CHEMBL4751886 179802 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 355 5 1 6 1.8 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(C2CC2)c(F)c1 nan
152007746 179974 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
CHEMBL4754043 179974 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 368 5 1 6 2.3 COc1ccn2c(=O)n(CC(=O)N[C@@H](C)c3c(C)cc(C)cc3C)nc2c1 nan
153585588 180194 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756392 180194 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 444 5 2 7 1.7 C[C@H](NC(=O)Cn1nc2c(N3CCC34CNC4)cccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585575 180237 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
CHEMBL4756937 180237 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 433 5 2 8 1.0 C[C@H](NC(=O)Cn1nc2c(N3CCNCC3)nccn2c1=O)c1ccc(Cl)c(F)c1 nan
153585415 180296 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
CHEMBL4757506 180296 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 2.1 CC(C(=O)N[C@@H](C)c1ccc(Cl)c(F)c1)n1nc2ncccn2c1=O nan
153585534 180492 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
CHEMBL4759991 180492 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 413 5 1 7 2.1 Cc1cnc2nn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)c(F)c3)c(=O)n2c1 nan
153585663 180563 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
CHEMBL4760812 180563 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 345 4 1 6 1.7 Cc1ccc([C@H](C)NC(=O)Cn2nc3ncccn3c2=O)cc1Cl nan
153585643 180749 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4762957 180749 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 381 5 1 7 1.7 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(OC(F)(F)F)cc1 nan
134043805 181177 1 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4777673 181177 1 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 362 6 1 6 2.0 CC(NC(=O)Cn1nc2ccccn2c1=O)c1ccc(OC(F)F)cc1 nan
153585542 181714 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
CHEMBL4784153 181714 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 365 4 1 6 2.1 C[C@H](NC(=O)Cn1nc2ncccn2c1=O)c1ccc(Cl)c(Cl)c1 nan
162667558 181870 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4786371 181870 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 331 4 1 6 1.4 C[C@H](NC(=O)Cn1nc2cccnn2c1=O)c1ccc(Cl)cc1 nan
147410414 182089 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
CHEMBL4789252 182089 0 None - 0 Rat 8.0 pEC50 = 8 Binding
Agonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assayAgonist activity at rat GPR139 expressed in CHO-K1 cells assessed as increase in calcium flux by calcium 5 dye based FLIPR assay
ChEMBL 363 4 1 6 1.9 Cc1ccnc2nn(CC(=O)N[C@@H](C)c3ccc(Cl)c(F)c3)c(=O)n12 nan
121349671 181161 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4777495 181161 0 None - 1 Human 8.0 pKi = 8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 350 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349806 182782 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4797857 182782 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349656 182897 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4799483 182897 0 None - 1 Human 8.0 pKi = 8.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 424 5 1 6 2.8 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3F)c(=O)c12 nan
121349756 181975 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4787761 181975 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
27785340 182879 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4799237 182879 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
27785340 182879 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4799237 182879 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
121349782 182452 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4794046 182452 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c2c1 nan
164619649 185174 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
CHEMBL4866435 185174 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccccc1Cl 10.1021/acs.jmedchem.1c00820
26810968 185691 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
CHEMBL4874147 185691 0 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1cccc2ccccc12 10.1021/acs.jmedchem.1c00820
11685 3667 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
121349608 3667 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
CHEMBL4779773 3667 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 10.1021/acs.jmedchem.1c00820
11685 3667 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349608 3667 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
CHEMBL4779773 3667 17 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 nan
121349786 181661 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4783626 181661 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349639 181825 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4785741 181825 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349786 181661 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
CHEMBL4783626 181661 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 404 7 1 7 2.3 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)F)cc3)c(=O)c12 nan
121349639 181825 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4785741 181825 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
2695546 185524 12 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871792 185524 12 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349600 181993 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
CHEMBL4788013 181993 0 None - 1 Human 6.9 pKi = 6.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c2c1 nan
121349548 182837 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798667 182837 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349548 182837 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798667 182837 1 None - 1 Human 5.9 pKi = 5.9 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 5 1 6 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349554 182947 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
CHEMBL4800089 182947 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(OC)ccc3c2=O)cc1 nan
36428174 181350 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4779855 181350 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 10.1021/acs.jmedchem.1c00820
36428174 181350 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4779855 181350 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 376 4 1 5 2.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349659 181673 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4783774 181673 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349593 182281 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
CHEMBL4791792 182281 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F 10.1021/acs.jmedchem.1c00820
121349593 182281 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
CHEMBL4791792 182281 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 394 4 1 5 2.8 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1F nan
121349633 182125 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
CHEMBL4789631 182125 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O 10.1021/acs.jmedchem.1c00820
121349633 182125 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
CHEMBL4789631 182125 0 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cc(C)ccc1[C@H](C)NC(=O)Cn1nnc2ccccc2c1=O nan
2714527 184813 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4861019 184813 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
2714528 181886 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
CHEMBL4786641 181886 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 308 4 1 5 1.7 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 nan
27838947 184839 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4861445 184839 2 None - 1 Human 5.8 pKi = 5.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 5 1 5 1.8 O=C(Cn1nnc2ccccc2c1=O)NCCc1cccc(Cl)c1 10.1021/acs.jmedchem.1c00820
121349658 182111 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4789475 182111 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 10.1021/acs.jmedchem.1c00820
121349658 182111 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
CHEMBL4789475 182111 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(F)c1 nan
121349597 181219 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
CHEMBL4778124 181219 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(Cl)ccc3c2=O)cc1 nan
121349631 181890 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4786722 181890 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349631 181890 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4786722 181890 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349615 182533 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
CHEMBL4795005 182533 0 None - 1 Human 6.8 pKi = 6.8 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 366 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cc(C)cc3c2=O)cc1 nan
121349564 181172 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4777630 181172 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349564 181172 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4777630 181172 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349588 181644 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4783365 181644 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 6 1 6 3.0 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
121349572 181254 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4778561 181254 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349572 181254 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4778561 181254 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 4 1 5 2.6 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349778 181764 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4784744 181764 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 3.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
164617980 184436 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
CHEMBL4855076 184436 0 None - 1 Human 5.7 pKi = 5.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)nc1 10.1021/acs.jmedchem.1c00820
121349738 181505 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
CHEMBL4781754 181505 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 5 1 5 3.1 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cc1 nan
121349559 181244 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
CHEMBL4778354 181244 0 None - 1 Human 6.7 pKi = 6.7 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc2c1 nan
164628435 185698 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4874254 185698 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1cccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c1 10.1021/acs.jmedchem.1c00820
8036946 182847 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798779 182847 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
8036946 182847 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
CHEMBL4798779 182847 2 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 nan
121349701 181352 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
CHEMBL4779884 181352 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)nnc12 nan
121349710 182356 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4792828 182356 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349675 181373 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
CHEMBL4780038 181373 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cc(Cl)cc3c2=O)cc1 nan
121349683 182131 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4789720 182131 0 None - 1 Human 7.6 pKi = 7.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)c(=O)c12 nan
121349753 182302 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4792136 182302 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 10.1021/acs.jmedchem.1c00820
121349753 182302 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
CHEMBL4792136 182302 0 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(OC)c1 nan
78596259 184783 1 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4860510 184783 1 None - 1 Human 5.6 pKi = 5.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 342 4 1 5 2.3 CC(NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Cl)cc1 10.1021/acs.jmedchem.1c00820
121349739 181578 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4782619 181578 0 None - 1 Human 6.6 pKi = 6.6 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 392 6 1 6 2.4 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)F)cc1 nan
2496250 28724 7 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL1380104 28724 7 None - 1 Human 5.5 pKi = 5.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 338 6 1 6 1.2 COc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349685 181541 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4782204 181541 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349685 181541 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
CHEMBL4782204 181541 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 440 6 1 7 2.7 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3F)c(=O)c12 nan
121349719 182667 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
CHEMBL4796493 182667 0 None - 1 Human 7.5 pKi = 7.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 nan
121349787 182080 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
CHEMBL4789079 182080 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cc(C)ccc3c2=O)cc1 nan
121349623 181508 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
CHEMBL4781805 181508 0 None - 1 Human 6.5 pKi = 6.5 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc12 nan
121349755 181211 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4778062 181211 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
121349773 181836 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
CHEMBL4785980 181836 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 406 5 1 6 2.7 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C(F)(F)F)cc3)nnc2c1 nan
121349614 181073 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
CHEMBL4776329 181073 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(C)c1 nan
121349720 181651 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
CHEMBL4783544 181651 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(OC)cccc3c2=O)cc1 nan
121349645 181126 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
CHEMBL4776988 181126 0 None - 1 Human 7.4 pKi = 7.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 410 5 1 6 2.7 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1 nan
164611430 184631 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
CHEMBL4857947 184631 0 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 377 4 1 6 2.1 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C(F)(F)F)cn1 10.1021/acs.jmedchem.1c00820
121349746 182792 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797979 182792 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349746 182792 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
CHEMBL4797979 182792 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 390 4 1 5 3.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C(F)(F)F)cc3c2=O)cc1 nan
121349745 181620 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4783071 181620 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 10.1021/acs.jmedchem.1c00820
121349745 181620 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
CHEMBL4783071 181620 0 None - 1 Human 6.4 pKi = 6.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc2c1 nan
8036887 184147 1 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
CHEMBL4850747 184147 1 None - 1 Human 5.4 pKi = 5.4 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.7 C[C@@H](CNC(=O)Cn1nnc2ccccc2c1=O)c1ccccc1 10.1021/acs.jmedchem.1c00820
121349781 181256 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4778563 181256 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
121349596 182849 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4798863 182849 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349596 182849 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4798863 182849 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 4 1 5 2.0 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
121349728 181224 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4778172 181224 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349728 181224 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
CHEMBL4778172 181224 0 None - 1 Human 7.3 pKi = 7.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c12 nan
121349688 182306 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
CHEMBL4792174 182306 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(F)c3c2=O)cc1 nan
27783537 181091 1 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4776509 181091 1 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 386 4 1 5 2.4 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(Br)cc1 10.1021/acs.jmedchem.1c00820
121349587 181820 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4785669 181820 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349769 182335 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4792561 182335 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349689 182627 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
CHEMBL4796061 182627 0 None - 1 Human 6.3 pKi = 6.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(Cl)cc3c2=O)cc1 nan
121349780 185777 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4875522 185777 0 None - 1 Human 5.3 pKi = 5.3 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 322 5 1 5 1.5 Cc1ccc(CCNC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349628 181433 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
CHEMBL4780801 181433 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 10.1021/acs.jmedchem.1c00820
121349628 181433 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
CHEMBL4780801 181433 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc2nnn(CC(=O)N[C@@H](C)c3ccc(C)cc3)c(=O)c2c1 nan
121349805 182528 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
CHEMBL4794908 182528 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 368 6 1 7 1.7 COc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(OC)c3c2=O)cc1 nan
27754276 185339 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4869182 185339 0 None - 1 Human 5.2 pKi = 5.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 5 1 5 2.4 CC[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(C)cc1 10.1021/acs.jmedchem.1c00820
121349734 181504 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
CHEMBL4781729 181504 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 10.1021/acs.jmedchem.1c00820
121349734 181504 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
CHEMBL4781729 181504 0 None - 1 Human 7.2 pKi = 7.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)c(C)c1 nan
121349574 182227 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4790968 182227 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 10.1021/acs.jmedchem.1c00820
121349574 182227 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
CHEMBL4790968 182227 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 374 6 1 6 2.3 C[C@H](NC(=O)Cn1nnc2ccccc2c1=O)c1ccc(OC(F)F)cc1 nan
121349569 181323 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
CHEMBL4779481 181323 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 340 4 1 5 2.1 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cccc3c2=O)cc1 nan
164609046 183893 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4847108 183893 0 None - 1 Human 6.2 pKi = 6.2 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.5 Cc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349561 182138 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
CHEMBL4789791 182138 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(C)cccc3c2=O)cc1 nan
121349719 182667 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
CHEMBL4796493 182667 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 422 6 1 7 2.6 COc1cccc2nnn(CC(=O)N[C@@H](C)c3ccc(OC(F)(F)F)cc3)c(=O)c12 10.1021/acs.jmedchem.1c00820
121349711 182275 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(F)c1 nan
CHEMBL4791752 182275 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 358 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)c(F)c1 nan
121349694 181623 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
CHEMBL4783106 181623 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 10.1021/acs.jmedchem.1c00820
121349694 181623 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
CHEMBL4783106 181623 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1cccc2c(=O)n(CC(=O)N[C@@H](C)c3ccc(C)cc3)nnc12 nan
121349679 185676 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4873905 185676 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 1.5 COc1ccc(C[C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349566 182060 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
CHEMBL4788831 182060 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 372 5 1 6 2.3 COc1ccc([C@H](C)NC(=O)Cn2nnc3c(Cl)cccc3c2=O)cc1 nan
164621186 185502 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871591 185502 0 None - 1 Human 5.1 pKi = 5.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 323 4 0 6 2.4 Cc1ccc([C@H](C)OC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349767 182738 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4797410 182738 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349767 182738 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
CHEMBL4797410 182738 0 None - 1 Human 7.1 pKi = 7.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 354 4 1 5 2.4 Cc1ccc([C@H](C)NC(=O)Cn2nnc3c(F)cc(C)cc3c2=O)cc1 nan
164620725 185493 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4871506 185493 0 None - 1 Human 6.1 pKi = 6.1 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.2 COc1ccc([C@H](C)NC(=O)C(C)n2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
121349809 182569 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
CHEMBL4795372 182569 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 356 5 1 6 1.8 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(F)cc3c2=O)cc1 nan
121349740 181499 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
CHEMBL4781651 181499 0 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 5 1 6 2.0 COc1ccc([C@H](C)NC(=O)Cn2nnc3ccc(C)cc3c2=O)cc1 nan
121349795 182857 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
CHEMBL4798933 182857 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 336 4 1 5 2.3 Cc1ccc([C@H](C)NC(=O)Cn2nnc3cccc(C)c3c2=O)cc1 nan
121349558 181380 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
CHEMBL4780121 181380 0 None - 1 Human 7.0 pKi = 7.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 428 5 1 6 2.8 C[C@H](NC(=O)Cn1nnc2ccc(F)cc2c1=O)c1ccc(OC(F)(F)F)cc1F nan
41757362 181621 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
CHEMBL4783081 181621 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 10.1021/acs.jmedchem.1c00820
41757362 181621 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
CHEMBL4783081 181621 1 None - 1 Human 6.0 pKi = 6.0 Binding
Displacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assayDisplacement of (S)-N-(1-(2-[3H]-4-methoxyphenyl)propan-2-yl)-2-(2,3-dimethyl-7-oxothieno[2,3-d]pyridazin-6(7H)-yl)acetamide, from human GPR139 expressed in CHO-TRex membranes incubated for 20 mins by scintillation counting assay
ChEMBL 352 6 1 6 2.1 CCOc1ccc([C@H](C)NC(=O)Cn2nnc3ccccc3c2=O)cc1 nan
2144 2314 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
3313 2314 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6140 2314 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
6925665 2314 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
CHEMBL301523 2314 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
DB00120 2314 0 None - 1 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 165 3 2 2 0.6 N[C@H](C(=O)O)Cc1ccccc1 26349500
2780 2331 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6305 2331 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
6923516 2331 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
717 2331 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
CHEMBL54976 2331 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
DB00150 2331 101 None -630 2 Human 3.1 pKi = 3.1 Binding
Inhibition equilibrium constant from a radioligand membrane binding assay.Inhibition equilibrium constant from a radioligand membrane binding assay.
Guide to Pharmacology 204 3 3 2 1.1 OC(=O)[C@H](Cc1c[nH]c2c1cccc2)N 26349500
11685 3667 17 None - 1 Human 6.9 pKi = 6.9 Binding
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
121349608 3667 17 None - 1 Human 6.9 pKi = 6.9 Binding
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
CHEMBL4779773 3667 17 None - 1 Human 6.9 pKi = 6.9 Binding
Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139Radioligand competition binding assay using membranes isolated from CHO-T-REx cells that stably express the hGPR139
Guide to Pharmacology 392 5 1 6 2.6 O=c1c2c(nnn1CC(=O)N[C@@H](C)c1ccc(cc1)OC(F)(F)F)cccc2 34260228
2548547 2109 39 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500
8766 2109 39 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500
CHEMBL3633720 2109 39 None - 1 Human 7.6 pKi = 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 316 5 2 2 2.9 O=C(N[C@H](c1ccccc1)C)CNC(=O)c1cccc(c1)Cl 26349500